Back to discover
Disease
Osteoarthritis, Hip
Late-stage therapeutic developmentEmerging research
1
Publications
19
Clinical trials
2008
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2008-02-01Osteoarthritis and cartilage
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 2 clinical trials expected to report results, the earliest in Q4 2026.
Upcoming Milestones
- Q4 2026ASCLEPIOS Autologous Stem CelL Expansion and Prospective Injection for Osteoarthritic Hip Symptoms
- Q2 2027A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip Arthroplasty
Major developments
Major trial resultsHigh impact
Results posted2026-01-07
Upcoming trial readoutImportant
Results expected Q2 20272026-07-01
Clinical MilestonesViewHide
Results posted
Results expected
- 2026-07-01A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip ArthroplastyResults expected Q2 2027
- 2025-11-17ASCLEPIOS Autologous Stem CelL Expansion and Prospective Injection for Osteoarthritic Hip SymptomsResults expected Q4 2026
Activity timeline3
- 2026-07-01ClinicalA Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip ArthroplastyResults expected Q2 2027
- 2026-01-07ClinicalA Phase 2/3 (Placebo-Controlled, Double-Blind, Comparative) Study on MT-5547 in Patients With Osteoarthritis Accompanied by Moderate to Severe PainResults posted
- 2025-11-17ClinicalASCLEPIOS Autologous Stem CelL Expansion and Prospective Injection for Osteoarthritic Hip SymptomsResults expected Q4 2026
Clinical trials
The current development programme across all trial phases.
Clinical programme
19
6
9
6
Late-stage studies
Recruiting
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Leading journals1
- Osteoarthritis and cartilage1
Leading researchers8
- Abramson S1
- Altman RD1
- Arden N1
- Bierma-Zeinstra S1
- Brandt KD1
- Croft P1
- Doherty M1
- Dougados M1
Affiliations (unnormalised)1
- University of Edinburgh1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Noninflammatory degenerative disease of the hip joint which usually appears in late middle or old age. It is characterized by growth or maturational disturbances in the femoral neck and head, as well as acetabular dysplasia. A dominant symptom is pain on weight-bearing or motion.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.